Compounding pharmacies are in the FDA’s headlights again, with another pharmacy receiving a warning letter after an inspection, these inspections normal have findings relating to poor design of pharmacy clean rooms, i.e. CFR 211.42. Highlighted below within the text are the top 10 ranking 2014/15 FDA warning letters trends, full list here. The Warning Letter included: … Continue reading USA FDA issues a warning letter to another compounding pharmacy